[DOI] [PMC free article] [PubMed] [Google Scholar] 165.Szopinska-Tokov J., Dam S., Naaijen J., Konstanti P., Rommelse N., Belzer C., Buitelaar J., Franke B., Bloemendaal M., Aarts E., et al
Patients appreciate Troy Watsons close supervision and approachable style, which make the early stages of Semaglutide GLP-1 therapy smooth and empowering
Cell Metab (2020) 32:676688.e4
Some medications may influence the action of others
Conclusion Tirzepatide marks a notable advancement in the management of type 2 diabetes and obesity, demonstrating its dual action on GLP-1 and GIP receptors to enhance insulin secretion and facilitate weight loss
Owing to poor glycemic control, the treatment was changed to liraglutide